About this Research Topic
Noninvasive multimodality molecular and functional imaging technologies are at the core of precision medicine because of their potential ability to make transformative advances in cancer and pre-cancer subtyping and in precision image-guided therapy of cancer. Theranostic imaging is a rapidly expanding aspect of molecular imaging that is creating exciting new possibilities for personalized precision medicine in cancer by combining diagnosis with therapy. Molecular imaging can be applied to identify targets specific to cancer with imaging, design agents against targets and visualize their delivery, monitor response to treatment, and minimize collateral damage to normal tissue. The purpose of this Research Topic is to present multi-modality applications of theranostic imaging that have the potential to achieve precision medicine of different aspects of the tumor ecosystem including cancer cells, stromal cells, immune cells, hypoxia and pH.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
